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Abstract 
BACKGROUND: Decrease or loss in splenic filtration function may influence the 
hemorheological state. 
OBJECTIVE: To follow-up the long-term effects of splenectomy, spleen autotransplantation 
and spleen resections on red blood cell aggregation in a canine model. 
METHODS: Beagle dogs were subjected to control (n=6), splenectomy (SE, n=4), spleen 
autotransplantation (AU, Furka’s spleen-chip method, n=8) or partial and subtotal spleen 
resection (n=4/each) groups, and followed-up for 18 postoperative (p.o.) months. Erythrocyte 
aggregation was determined in parallel by light-transmittance aggregometry (Myrenne MA-1 
aggregometer) and syllectometry (LoRRca).  
RESULTS: Erythrocyte aggregation decreased three months after splenectomy, with lower 
aggregation index and elongated aggregation time. It was more or less associated with 
relatively lower hematocrit and fibrinogen concentration. However, in autotransplantated 
animals a relatively higher fibrinogen did not increase the aggregation markedly. Spleen 
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resection resulted in the most controversial red blood cell aggregation findings, and it seems, 
that the degree of the resection is an influencing factor.  
CONCLUSIONS: Splenectomy alters erythrocyte aggregation, spleen autotransplantation 
can be useful to preserve filtration function. However, the degree of restoration shows 
individual differences with a kind of ‘functional periodicity’. Spleen resection controversially 
influences erythrocyte aggregation parameters. The subtotal resection is supposed to be worse 
than spleen autotransplantation. 
 
Keywords: spleen filtration function, splenectomy, spleen autotransplantation, spleen partial 
or subtotal resection, red blood cell aggregation  
 
 
1. Introduction 
Filtration, immunological and storage function of the spleen has been revealed in the 
past decades. Loss of these functions may lead to the often fatal overwhelming 
postsplenectomy infection (OPSI) syndrome, and/or may increase the risk of thromboembolic 
complications [4,5,11,19,23]. Thus, in case of traumatic or intraoperative injury of the 
otherwise healthy spleen, the organ sparing surgical approach is highly recommended 
[6,10,21,24]. 
Decrease or loss in splenic filtration function may influence the hemorheological state, 
since the elimination of the damaged and/or elder red blood cells is altered, as it has been 
demonstrated by our previous studies as well [1-3,9,13,14,16,22]. Red blood cell aggregation 
is determined by several cellular (cell shape-morphology, membrane strain, deformability, 
cell surface glycocalyx structure) and plasmatic factors (macromolecules) [1,2]. These factors 
may alter after splenectomy (asplenic state) or in case of decreased splenic functions 
(hyposplenic state) [9,14,16]. It is believed that micro-rheological parameters, such as 
erythrocyte deformability and aggregation might serve as a good supplementary marker in 
screening and following-up splenic filtration function [13,14,16]. 
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In recent study we aimed to follow-up the long-term effects of splenectomy, spleen 
autotransplantation (spleen ‘chips’ placed in between the sheets of the greater omentum 
[7,8]), and spleen resections at various degree [7], using complex investigative methods. From 
these results we show the red blood cell aggregation parameters in this paper. 
 
2. Materials and methods 
2.1. Experimental animals and operative techniques  
The experiments were approved by the University of Debrecen Committee of Animal 
Welfare (permission Nr.: 26/2011/UDCAW) in accordance with the national regulations (Law 
XXVIII/1998) and EU  directives (2010/63).  
Twenty-six healthy male and female beagle dogs (age: 18-23 months, body weight: 
12.98±1.1 kg) were involved in this study. All the operations were performed in sterile 
condition under general anesthesia with intramuscularly administered combination of 
ketamine and xylazine (10 mg/bwkg, CP-Ketamin, ketamine hydrochloride 10% + 1 
mg/bwkg, CP-Xylazin, xylazine-hydrochloride 2%; Produlab Pharma BV, The Netherlands). 
 
Animals were subjected to one of the following experimental groups: 
I. Control group (C, n=6): This group contains the sham operated and healthy control 
animals as well. In sham operated control animals (n=3) median laparotomy was 
performed, while in healthy controls (n=3) there was no any surgical intervention.  
II. Splenectomy group (SE, n=4): after median laparotomy the spleen was removed.  
III. Spleen-autotransplantation group (AU, n=8): after median laparotomy and the 
consecutive  splenectomy, ten pieces of splenic slices (20 mm x 50 mm x 1 mm) were 
placed between two layers of the greater omentum, close to a well-vascularized area 
according to the ‘Furka’s spleen chip’ method [7,8].  
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IV. One-third (partial resection) and two-third (subtotal) spleen resection groups (R1/3 
and R2/3, n=4/each): After median laparotomy one-third or two-third part of the distal 
region of the spleen was resected) using ‘Furka-type’ embracing suture technique [7].  
 
In every operated group the abdominal wall was closed in two layers. First the muscle and 
peritoneum were closed with 1-0 polyglycolic acid absorbable suture material (Optime®, 
Peters Surgical, France) using simple interrupted stitches, then to close the skin 2-0 
polyglycolic acid absorbable suture material  (Optime®, Peters Surgical, France) using Donati 
vertical mattress stitches were used. 
 
2.2. Blood sampling protocol 
Regarding the presented parameters in this paper, blood samples were taken before the 
operations (base) and in the 1st, 3rd, 6th, 9th and 18th postoperative months via puncturing the 
cephalic vein using closed blood sampling system with 21 G BD EclipseTM needles (Becton, 
Dickinson and Company, USA). For hematological and red blood cell aggregation tests K3-
EDTA was used as anticoagulant (1.8 mg/ml, BD Vacutainer®), while fibrinogen 
concentration was determined in plasma from blood anticoagulated with sodium-citrate (0.129 
M, BD Vacutainer® tubes).  
 
2.3. Testing hematological parameters 
Quantitative and qualitative hematological parameters were determined using an 
Advia 120 hematology automate (Siemens Healthcare Gmbh, Germany). The measurements 
require 175 µl of blood sample. In this study we focused on the hematocrit, as a major red 
blood cell aggregation determinant hematological parameter.  
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2.4. Measuring fibrinogen concentration 
Fibrinogen concentration (Fbg [g/l]) of the plasma was determined using a Sysmex 
CA-500 coagulometer (TOA Medical Electronics Co., Ltd., Japan) based on the Clauss’s 
method. 
 
2.5. Determining red blood cell aggregation 
2.5.1. Light-transmittance aggregometry 
For testing the red blood cell aggregation a Myrenne MA-1 erythrocyte aggregometer 
(Myrenne GmbH, Germany) was used. The technique is based on light-transmittance 
photometric method. The test requires approximately 20 µl of blood. During the 
measurements the sample is disaggregated (at 600 s-1) then the shear rate drops to zero (M 
mode) or to 3 s-1 (M1 mode). According to the changes in light-transmittance the instrument 
calculates the aggregation index values at the 5th or 10th second of the process. The indices 
(M 5s, M 1 5s, M10 s, M1 10s) increase with enhanced red blood cell aggregation [1,2]. 
 
2.5.2. Syllectometry 
In parallel with the light-transmission technique, erythrocyte aggregation was also 
tested with a LoRRca MaxSis Osmoscan ektacytometer (Mechatronics BV, Hollandia) 
operating with laser-backscattering method. The tests require 1 ml of blood. 
After disaggregating the blood sample with rotation in the Couette-system, the rotor 
stops and the changes in the intensity of the light reflected from the sample is measured. From 
the intensity-time curve the software calculates several parameters, including aggregation 
index (AI [%]), amplitude (Amp [au]) and aggregation half time (half-amplitude time, t1/2 [s]), 
describing the rate, magnitude and the kinetics of the aggregation process [1,2]. 
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2.6. Statistical analysis 
Data are presented as mean values with standard deviation (means ± S.D.). Intra-group 
analyses were carried out with ANOVA tests (Bonferroni’s or Dunn’s post hoc tests). For 
inter-group comparisons at definitive time points of the follow-up period Student’s t-test or 
Mann-Whitney rank sum tests were used, depending on the data distribution. A p value of 
<0.05 was considered to be significant. 
 
 
3. Results 
3.1. Changes of hematocrit and fibrinogen concentration 
Absolute values of hematocrit (Htc [%]) and fibrinogen concentration (Fbg [g/dl]) are 
shown in Table 1, and their changes compared to base values are plotted in Figure 1. 
In Control group hematocrit did not change markedly over the follow-up period. In the 
other groups values dropped by the 1st postoperative months, and with the exception of 
splenectomy group, hematocrit fluctuated at various degrees in the groups, and never reached 
the base values. In Splenectomy group Htc were significantly lower over the entire follow-up 
period compared to the base (relative values, 1st month: p=0.009; 3rd month: p<0.001; 6th 
month: p<0.001; 9th month: p=0.002; 18th month: p=0.057) or to Control (1st month: p=0.042; 
3rd month: p=0.013; 6th month: p=0.035; 9th month: p=0.019). In Autotransplantation group 
although the values were higher, but still being significantly lower compared to base (relative 
values, 1st month: p=0.01; 3rd month: p<0.001; 6th month: p<0.001; 9th month: p=0.016; 18th 
month: p=0.002), and in the 1st and 3rd months versus the Control (p=0024 and p=0.008, 
respectively). Spleen resection groups’ values started to ‘normalize’ after the 1st month, 
however, the subtotal resection (R2/3) resulted in lower values (versus base: p=0.09 in the 1st 
and 3rd months; versus Control: p=0.052 in the 9th month). 
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Fibrinogen concentration showed a slight and non-significant increase in Control 
group. In Splenectomy group values showed an increase in the 6th and by the 18th months 
(p=0.057 vs. base). In Autotransplantation group, except for two animals, values increased by 
the 1st month (relative values, p=0.01 vs. base, p=0.08 vs. Control), and expressed further 
elevated values from the 6th month compared to the base (6th month: p=0.021; 9th month: 
p=0.02; 18th month: p=0.002). The R1/3 group did not show important difference from the 
Control, except for a decrease by the end of the follow-up period. However, in subtotal 
resection (R2/3) group fibrinogen values were permanently lower than the control, reaching 
significant difference in the 3rd (p=0.09 vs. base; p=0.059 vs. AU), 6th (p=0.02 vs. base; 
p=0.016 vs. AU), 9th month (p=0.006 vs. base; p=0.048 vs. Control) and 18th month (p=0.026 
vs. AU). 
 
3.2. Red blood cell aggregation parameters by light-transmission aggregometry 
Table 2 summarizes the aggregation index parameters tested by the Myrenne MA-1 
aggregometer. 
Parameters of the Control group showed a relative stability over the follow-up period, 
except for an increase in the 18th month (M 10 s: p<0.001; M1 5 s: p=0.014; M1 10 s: p=0.01 
vs. base).  
In Splenectomy group index values dropped by the 3rd postoperative month (M 5 s: 
p=0.053 vs. base, p<0.001 vs. Control; M 10 s: p=0.009 vs. base, p<0.001 vs. Control; M1 5 
s: p<0.001 vs. base and Control; M1 10 s: p<0.001 vs. base and Control). The animal Nr. SE-
3 showed the lowest M1 10 s index values. Afterwards the data started to ‘normalize’.  
Autotransplantation group also expressed a decrease in values by the 3rd month, 
however, in smaller manner compared to the SE animals (M 10 s: p=0.012 vs. base, p=0.002 
vs. Control and SE; M1 5 s: p=0.005 vs. base). By the 18th month index values increased (M 5 
 8
s: p=0.025 vs. base; M 10 s: p=0.005 vs. base; M1 5 s: p<0.001 vs. base, p=0.001 vs. SE; M1 
10 s: p<0.001 vs. base and SE). The animal Nr. AU-4 expressed the highest aggregation index 
values amongst the others (M 5 s, M 10s and M1 5s). 
Data of the resection groups changed irregularly. By the 3rd months M 10 s (p=0.003 
vs. base; p<0.001 vs. Control) and M1 10 s values (p=0.01 vs. base; p<0.001 vs. Control) 
dropped in R1/3 group, while M 5 s increased (p=0.009 vs. base) and M1 5 s was similar to 
the base. Over the 6th-9th month values were relatively stable. By the 18th months M1 5 s 
(p<0.001 vs. base) and M1 10 s values increased (p=0.003 vs. base, p<0.001 vs. Control), and 
M 10 s were almost unchanged. In R2/3 (subtotal resection) group by the 18th month M 10 s 
data were higher (p<0.001 vs. base, p=0.009 vs. Control), M1 5 s and M1 10 s lower (p=0.005 
vs. Control), and M 5 s values similar to the R1/3 group’s data. 
 
3.3. Red blood cell aggregation parameters by syllectometry 
Absolute values are shown in Table 2, and their changes compared to base values are 
plotted in Figure 2. 
Aggregation index (AI) tested by the LoRRca was almost unchanged in Control group, 
except for a slight but non-significant lowering in the 6th and 9th months. Values of the 
Splenectomy group rose by the 1st month and dropped in the 3rd (relative values, p=0.045). 
After a relative increase in the 6th month, we could see another decrease by the 9th months 
(p<0.001 vs. base). Autotransplanted animals showed increase by the 1st month, then the 
values were relative stable over the follow-up period. In resection groups values were 
suppressed between the 3rd and 9th month (R1/3 group, 3rd month: p=0.004, 6th month: 
p<0.001, 9th month: p=0.003 vs. base; R2/3 – subtotal resection group, 3rd month: p=0.067, 6th 
month: p=0.03).  
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Amplitude increased in Control groups over the follow-up period. In Splenectomy 
(p=0.051 vs. Control), Autotransplantation (p=0.065 vs. base) and R1/3 groups the values 
decreased by the 3rd month, then elevated again. In R2/3 (subtotal resection) group increased 
Amp data were obtained. 
The aggregation half-time (t1/2) rose in all groups, but most expressedly in the 
Splenectomy and the two Resection groups between the 3rd (SE group: p=0.077 vs. base; R2/3 
– subtotal resection group: p=0.03 vs. base) and 9th months (SE group: p=0.029 vs. base; R1/3 
resection group: p=0.007 vs. base). 
 
4. Discussion 
Red blood cell aggregation is determined by several plasmatic and cellular factors that 
might be modified in numerous pathophysiological conditions, such as metabolic, acid-base 
and oxygenization changes, free-radical effects, acute phase reactions, inflammation, sepsis 
[1,2]. Any conditions that influence cell shape, deformability, ultrastructure of the surface 
glycocalyx and the plasmatic microenvironment might have an effect on the aggregation 
process [1,2,17]. By in vitro studies the red blood cell aggregability can be well studied. 
However, in vivo conditions often provide controversial results. We have experienced that 
changes of red blood cell deformability and aggregation are not always correlated to each 
other. Usually the increased hematocrit and fibrinogen concentration result in enhanced red 
blood cell aggregation. On the other hand, increased aggregation can be even found when 
hematocrit or fibrinogen data does not support this finding. The in vivo changes and effects of 
red blood cell aggregation must be more complex than it has been thought. Methods that can 
test both ‘static’ and ‘dynamic’ parameters of the aggregation process give valuable 
information [1,2,18]. 
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In this canine experimental series we have found that red blood cell aggregation in 
peripheral blood decreased three months after splenectomy, with low aggregation index and 
elongated aggregation time (Table 2, Figure 2). Generally, a decrease in aggregation can be 
explained by lowered hematocrit and/or fibrinogen concentration, as well as by morphological 
changes of the cells and/or altered deformability. We did not found deformability impairment 
at that time. The changes were more or less associated with a relatively lower hematocrit and 
fibrinogen concentration (Table 1, Figure 1). However, in autotransplantated animals a 
relatively higher fibrinogen did not increase aggregation markedly. Filtration function can be 
partly restored by the reticulo-endothelial system (liver, bone marrow), therefore histological 
examination of those organs may provide necessary information for the evaluation. 
When splenic filtration function is decreased or disappears, the micro-rheological 
parameters of the peripheral blood can be impaired. Decreased deformability, altered (more 
often enhanced) red blood cell aggregation occurs, with higher amount of elder erythrocyte 
subpopulation in the circulation [1,2]. 
In 2010 we published red blood cell aggregation results in a 24-month follow-up 
series, highlighting the 20th and 24th months [12], but without any spleen resection groups. 
According to the main findings hematocrit decreased in SE, AU-5 (spleen autotransplantation 
with 5 ‘chips’) and AU-10 (spleen autotransplantation with 10 ‘chips’) groups, fibrinogen 
concentration did not change essentially, aggregation index values increased by the 12th 
month in SE, AU-5 and AU-10 groups. Aggregation index values of various red blood cell 
populations (‘young’ versus ‘old’) showed the largest differences in SE group, while AU 
groups expressed lower values. As conclusion we could state that an increase in erythrocyte 
aggregation index may reflect the lost or decreased filtration function after splenectomy or 
autotransplantation, and by comparing aggregation properties of ‘young’ and ‘old’ red blood 
cells, further information can be gained about the splenic filtration function [12]. 
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When analyzing the data obtained during the follow-up period it is also important to 
count with the ageing [2,12] and the seasonal effects [20]. These might explain the 
background of those slight changes in hematocrit, fibrinogen concentration and certain red 
blood cell aggregation parameters. 
Spleen autotransplantation could partly restore the splenic filtration function. Also it is 
supposed that the amount of the autotransplanted splenic tissue is related with the restoration 
degree of the splenic function. In previous canine and murine studies we found that compared 
to control animals, significantly elongated relative cell transit times (RCTT; inversely 
proportional to red blood cell deformability) are existed following splenectomy, while 
autotransplantation seemed to improve these values and showing irregular alterations during 
the postoperative weeks and months. It is also important to note that time is needed for 
neovascularization and regeneration of the autotransplanted splenic chips. Approximately 4-6 
months are necessary for regeneration, which process may also show a kind of ‘functional 
periodicity’ [9,13-16]. Current results enforce our previous findings with light- and electron 
microscopical [13,15] and laboratory methods [9,13-15]: „These laboratory investigations of 
different surviving times also suggested that there may be certain functional periodicity of the 
spleen chips, showing hyposplenic and asplenic states” [13]. 
Spleen resection resulted in the most controversial red blood cell aggregation findings, 
and it seems, that the degree of the resection is an influencing factor. The subtotal (two-third) 
spleen resection is supposed to be worse than spleen autotransplantation. However, further 
studies are necessary to clarify this issue. 
It is also important to mention that besides the general statistical analysis of 
experimental groups, the individual evaluation of the cases is highly important: general 
condition of the animals, possible complications, symptoms. To better understand the 
background of the alterations, the individual analysis of other laboratory parameters (e.g., 
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hematological, hemostaseological, enzymological, etc) and the complex histological 
examinations are necessary.  
 
5. Conclusion 
Splenectomy alters red blood cell aggregation, spleen autotransplantation can be useful 
to preserve filtration function. However, the degree of restoration shows individual 
differences and we have to face a kind of ‘functional periodicity’. Spleen resection 
controversially influences red blood cell aggregation parameters, more obviously in case of 
subtotal (two-third) resection. Individual analysis of hemorheological changes together with 
hematological, hemostaseological, enzmyological investigations, functional imaging 
techniques as well as complex histological examinations may provide more accurate 
information to screen the degree of restoration of the splenic filtration function in these organ 
preserving surgical operative techniques. 
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Table 1. Changes of hematocrit (Htc [%]) and fibrinogen concentration (Fbg [g/dl]) in control, splenectomy (SE), spleen autotransplantation (AU) and spleen 
resection groups (R1/3, R2/3) during the follow-up period of 18 months. 
 
Variable Experimental group Base 
 Postoperative month 
        1st          3rd    6th       9th  18th  
Htc [%] 
Control 43.24 ± 1.90 43.24 ± 1.70 44.66 ± 4.76 41.08 ± 4.76 41.86 ± 2.17 42.84 ± 3.84 
SE 45.8 ± 3.36 39.6 ± 5.37 37.5 ± 2.82 * # 37.95 ± 0.96 * 38.3 ± 1.08 * # 39.13 ± 1.16 * 
AU 46.95 ± 3.62 39.77 ± 3.65 *  39.7 ± 2.76 * 41.01 ± 1.88 * + 41.25 ± 3.12 * 41.42 ± 2.28 * 
R1/3 44.35 ± 0.44 40.65 ± 2.56 * 44.4 ± 6.10 + 42.65 ± 3.15 41.15 ± 5.57 39.2 ± 3.47 * 
R2/3 46.02 ± 4.89 41.87 ± 2.27 39.87 ± 2.13 * 41.7 ± 1.92 + 39.1 ± 1.34 * 38.56 ± 2.85 * 
Fbg [g/dl] 
Control 2.3 ± 0.15 2.26 ± 0.41 2.44 ± 0.30 2.74 ± 0.52 2.45 ± 0.43 2.58 ± 1.25 
SE 1.98 ± 0.94 1.57 ± 0.60 1.59 ± 0.27 # 2.47 ± 0.35 1.96 ± 0.68 1.88 ± 0.34 
AU 1.5 ± 0.23 2.06 ± 0.47 * 1.77 ± 0.59 # 2.13 ± 0.56 # 1.9 ± 0.37 # 2.29 ± 0.25 * 
R1/3 2.04 ± 0.68 2.02 ± 0.56 1.76 ± 0.13 # 2.06 ± 0.29 # 1.73 ± 0.21 # 2.07 ± 0.09 
R2/3 2.62 ± 0.43 2.14 ± 0.71 1.94 ± 0.15 # 2.09 ± 0.40 2.01 ± 0.27 2.13 ± 0.03 
SE – splenectomy group, AU – spleen autotransplantation group, R1/3 and R2/3 – one-third and two-third (subtotal) spleen resection groups  
means ± S.D., * p<0.05 vs. Base,  # p<0.05 vs. Control,  + p<0.05 vs. SE 
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Table 2. Changes of red blood cell aggregation parameters in control, splenectomy (SE), spleen autotransplantation (AU) and spleen resection groups (R1/3, 
R2/3) during the follow-up period of 18 months. 
 
Variable Experimental group Base 
Postoperative month
        1st          3rd   6th     9th 18th  
M 5 s 
Control 4.29 ± 1.89 4.07 ± 0.93 3.56 ± 1.25 4.23 ± 0.86 3.28 ± 1.43 4.94 ± 1.56 
SE 2.96 ± 1.85 4.1 ± 1.01 1.95 ± 0.78 * # 3.19 ± 0.74 3.14 ± 0.85 2.8 ± 1.77 
AU 3.54 ± 1.95 3.57 ± 1.73 2.58 ± 1.34 3.85 ± 0.89 3.71 ± 1.24 6.31 ± 4.51 * 
R1/3 4.53 ± 1.16 3.76 ± 1.1 5.73 ± 3.49 # + 2.56 ± 0.67 * 2.79 ± 1.19 * 3.61 ± 1.86 
R2/3 2.96 ± 1.39 4.11 ± 1.5 3.21 ± 0.81 3.67 ± 1.62 2.68 ± 0.8 3.5 ± 1.72 
M 10 s 
Control 12.25 ± 3.96 13.66 ± 3.58 11.16 ± 2.63 11.58 ± 2.46 10.69 ± 3.43 16.68 ± 4.41 * 
SE 10.2 ± 4.64 10.04 ± 2.24 5.88 ± 2.23 * # 10.89 ± 1.95 9.52 ± 3.52 10.63 ± 4,66 # 
AU 11.38 ± 4.59 13.04 ± 5.59 8.66 ± 3.03 * # + 11.96 ± 2.62 10.15 ± 2.26 15.13 ± 4.26 * 
R1/3 10.93 ± 5.91 11.33 ± 3.48 4.8 ± 2.43 * # 8.64 ± 2.51 9.09 ± 2.84 10.18 ± 5.67 # 
R2/3 7.95 ± 3 11.66 ± 2.54 * 8.24 ± 2.35 # + 11.34 ± 1.81 * 10.13 ± 2.67 12.36 ± 4.38 * # 
M1 5 s 
Control 5.3 ± 1.6 4.8 ± 1.03 4.95 ± 1.14 5.11 ± 1.41 4.35 ± 1.35 6.64 ± 2.01 * 
SE 5 ± 0.96 4.15 ± 0.97 2.81 ± 0.74 * # 3.65 ± 0.9 * 3.52 ± 0.94 * 4.78 ± 0.86 
AU 4.83 ± 2.27 4.18 ± 1.25 3.46 ± 1.01 * 4.53 ± 1.52 3.94 ± 1.37 8.79 ± 4.74 * + 
R1/3 4.41 ± 1.92 4.66 ± 1.74 5.37 ± 1.6 4.76 ± 1.09 3.69 ± 1.96 7 ± 0.58 * 
R2/3 6.02 ± 2.73 3.98 ± 0.98 * 4.22 ± 0.82 4.6 ± 1.58 3.51 ± 1.2 * 5.62 ± 0.75 
M1 10 s 
Control 12.28 ± 3.44 11.56 ± 4.05 11.18 ± 2.15 12.76 ± 2.5 9.93 ± 4.21 16.01 ± 5.18 * 
SE 13.08 ± 3.31 9.38 ± 4.16 * 6.69 ± 2.49 * # 9.81 ± 3.38 8.62 ± 2.4 10.47 ± 3.17 # 
AU 10.53 ± 3.82 10.23 ± 5.23 8.91 ± 4.06 # 11.08 ± 3.73 8.69 ± 3.8 17.16 ± 3.34 * + 
R1/3 10.73 ± 4.58 9.3 ± 2.28 6.44 ± 4.12 * # 9.63 ± 3.14 # 9.97 ± 3.91 15.9 ± 2.21 * + 
R2/3 9.5 ± 2.74 9.38 ± 2.83 9.24 ± 1.79 # 10.48 ± 2.78 8.24 ± 1.89 10.68 ± 4.52 # 
AI 
Control 55.61 ± 5.42 53 ± 4.79 52.18 ± 4.17 51.72 ± 8.81 45.27 ± 5.45 56.38 ± 7.1 
SE 44.53 ± 14.3 48.26 ± 3.88 22.95 ± 9.89 * # 44.42 ± 5.15 33.16 ± 9.94 * 33.57 ± 7.09 # 
AU 43.86 ± 9.86 51.47 ± 11.6 42.16 ± 6.79 # + 44.19 ± 7.75 41.44 ± 7.75 47.51 ± 5.56 + 
R1/3 51.6 ± 9.55 46.53 ± 6.61 37.52 ± 5.04 * # + 38.61 ± 4.54 34.12 ± 7.5 * 44.18 ± 5.69 # + 
R2/3 51.27 ± 13.09 55.66 ± 4.94 40.32 ± 5.26 # + 39.33 ± 12.12 42.99 ± 5.46 44.86 ± 2.31 # + 
Amp 
Control 20.43 ± 2.66 23.97 ± 3.16 * 21.82 ± 4.88 25.15 ± 1.06 * 24.39 ± 0.84 * 23.09 ± 1.55 * 
SE 18.43 ± 3.97 20.35 ± 2.65 13.13 ± 3.29 * # 19.6 ± 5.06 18.8 ± 3.69 18.14 ± 0.69 # 
AU 20.7 ± 3.59 20.76 ± 5.79 16.81 ± 2.57 * # + 22.51 ± 2.13 21.93 ± 3.02 20.4 ± 4.43 
R1/3 22.05 ± 2.75 23.54 ± 2.8 17.26 ± 2.59 * # + 22.27 ± 1.04 21.61 ± 1.9 23.63 ± 2.71 + 
R2/3 16.29 ± 2.65 21.15 ± 3.09 17.9 ± 3.7 + 22.78 ± 4.11 * 22.16 ± 2.39 * 21.4 ± 3.43 * + 
t1/2 [s] 
Control 3.25 ± 0.9 3.61 ± 0.79 3.68 ± 0.71 3.98 ± 1.72 5.06 ± 1.2 * 3.14 ± 0.79 
SE 5.87 ± 2.69 4.36 ± 0.65 14.88 ± 5.96 * # 5.2 ± 1.15 9.16 ± 3.48 * # 8.54 ± 2.87 # 
AU 5.6 ± 2.05 4.25 ± 2.26 5.84 ± 1.77 5.46 ± 2.04 6.49 ± 3.5 4.57 ± 1.11 + 
R1/3 4.02 ± 1.77 4.81 ± 1.19 6.96 ± 1.33 * + 6.63 ± 1.42 8.57 ± 2.52 * # 5.24 ± 1.36 + 
R2/3 4.28 ± 2.39 3.22 ± 0.72 6.19 ± 1.22 7.06 ± 3.16 5.54 ± 1.22 + 5.04 ± 0.46 + 
SE – splenectomy group, AU – spleen autotransplantation group, R1/3 and R2/3 – one-third and two-third (subtotal) spleen resection groups  
means ± S.D., * p<0.05 vs. Base,  # p<0.05 vs. Control,  + p<0.05 vs. SE 
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9. Figure legends and figures 
 
Figure 1 
Changes (relative to base) of hematocrit (rel. Htc) (A) and fibrinogen concentration (rel. Fbg) 
(B) in the sequence of control, splenectomy (SE), spleen autotransplantation (AU) and spleen 
resection groups (R1/3, R2/3: one-third and two-third -subtotal- spleen resection groups) 
during the 18-month follow-up period. 
means ± S.D., * p<0.05 vs. Base,  # p<0.05 vs. Control, + p<0.05 vs. SE (splenectomy) 
 
 
Figure 2 
Changes (relative to base) of aggregation index parameters determined by the LoRRca device: 
aggregation index (rel. AI) (A), amplitude (rel. Amp) (B) and time at half-Amp (rel. t1/2) in the 
sequence of control, splenectomy (SE), spleen autotransplantation (AU) and spleen resection 
groups (R1/3, R2/3: one-third and two-third -subtotal- spleen resection groups) during the 18-
month follow-up period. 
means ± S.D., * p<0.05 vs. Base,  # p<0.05 vs. Control, + p<0.05 vs. SE (splenectomy) 
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